BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2956487)

  • 21. Haemostasis in menstrual endometrium in the presence of an intrauterine device.
    Christiaens GC; Sixma JJ; Haspels AA
    Br J Obstet Gynaecol; 1981 Aug; 88(8):825-37. PubMed ID: 7260004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
    Niaraki MA; Moghissi KS; Borin K
    Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic removal of translocated intrauterine contraceptives devices.
    McKenna PJ; Mylotte MJ
    Br J Obstet Gynaecol; 1982 Feb; 89(2):163-5. PubMed ID: 6461352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
    Ulstein M; Steier AJ; Hofstad T; Digranes A; Sandvei R
    Acta Obstet Gynecol Scand; 1987; 66(4):321-2. PubMed ID: 3122515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the intrauterine contraceptive device on protein components of human uterine fluid.
    Tauber PF; Cramer GM; Zaneveld LJ
    Contraception; 1993 Nov; 48(5):494-512. PubMed ID: 8275697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of action of the copper intrauterine device.
    Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
    Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of the intrauterine contraceptive device on endometrial secretory function: a possible mode of action.
    Seif MW; Aplin JD; Awad H; Wells D
    Contraception; 1989 Jul; 40(1):81-9. PubMed ID: 2476276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
    Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
    Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrauterine contraceptive devices in diabetic women.
    Gosden C; Steel J; Ross A; Springbett A
    Lancet; 1982 Mar; 1(8271):530-5. PubMed ID: 6120391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the intrauterine contraceptive device on endometrial enzyme and carbohydrate histochemistry.
    Hester LL; Kellett WW; Spicer SS; Williamson HO; Pratt-Thomas HR
    Am J Obstet Gynecol; 1970 Apr; 106(8):1144-54. PubMed ID: 4314520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ characterization of leukocytes in the fallopian tube in women with or without an intrauterine contraceptive device.
    Wollen AL; Sandvei R; Mørk S; Marandon JL; Matre R
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):103-12. PubMed ID: 8116347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological changes in tubal mucosa associated with the use of intrauterine contraceptive devices.
    Wollen AL; Flood PR; Sandvei R; Steier JA
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1123-8. PubMed ID: 6498128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An explanation of the mechanism of preventing pregnancy by IUCD.
    Blum M; Ariel J; Pery J
    Br J Sex Med; 1983 Oct; 10(10):30-2. PubMed ID: 12265802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No increase of the fibrinolytic activity of the human endometrium by progesterone-releasing IUD (ProgestasertR).
    Liedholm P; Sjöberg NO; Srivastava K; Astedt B
    Contraception; 1978 Jun; 17(6):531-6. PubMed ID: 720058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scanning and transmission electron microscopy of material adherent to intrauterine contraceptive devices.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):155-62. PubMed ID: 7362803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.